Trial Profile
A Pharmacoepidemiological Study on the Association Between Bicalutamide Treated Prostate Cancer and Risk of Coronary Heart Disease (CHD) and Heart Failure (HF) in the General Practice Research Database (GPRD)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Feb 2013
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 24 Jun 2008 New trial record.